Cancer Markers of the 1990s: An Introduction. Clinical Cancer Markers: Diagnosis, Prognosis, and Monitoring. Alpha-Fetoprotein in the 1990s. Carcinoembryonic Antigen. Prostate-Specific Antigen. Enzyme Markers. Alkaline Phosphatases as Tumor Markers. Sex-Associated Hormones. Tissue Polypeptide Antigen and Specific TPA. Tumor-Associated Carbohydrate Markers: Chemical and Physical Basis and Cell Biological Implications. Glycoamines: Structural-Functional Characterization of a New Class of Human Tumor Markers. CA 15-3 Assay for the Detection of Episialin: A Serum Marker for Breast Cancer. Clinical Applications of CA 15-3. CA 19-9, GICA (Gastrointestinal Cancer Antigen). Mucin-Like Cancer-Associated Antigen (MCA) as Available Circulating Tumor Marker for Breast Cancer. DU-PAN-2: A Clinically Useful Mucin Marker of Differentiation of Pancreatic and Other Ductal Cells and Their Tumors. CA 50. TAG-72 as a Tumor Marker. CA 125. CA 242. Squamous Cell Carcinoma Antigen. Tumor-Marker Detection by Isotachophoresis in Porous Membranes: Bence-Jones Protein in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma. Multiple Testing with Cancer Markers. New Cancer Products: Predicting Market Success. Comments. Index.
Springer Book Archives